Rating History for Innate Pharma S.A. (IPHA) by Lucid Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/23/2025 | Christopher Liu | New Coverage | Buy (N/A) |
8.00 (N/A) |
2.09 (1.60) |
-23.44% | Details |
